Kornitzer Capital Management’s Abiomed Inc ABMD Stock Holding History

Kornitzer Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,700	Closed	-$1.65M	–	527
2022 Q3	$1.65M	Hold	6,700	–	–	0.04%	343
2022 Q2	$1.66M	Hold	6,700	–	–	0.03%	357
2022 Q1	$2.22M	Hold	6,700	–	–	0.04%	338
2021 Q4	$2.41M	Hold	6,700	–	–	0.04%	354
2021 Q3	$2.18M	Hold	6,700	–	–	0.03%	360
2021 Q2	$2.09M	Hold	6,700	–	–	0.03%	365
2021 Q1	$2.13M	Buy	6,700 +1,170	+21%	+$374K	0.03%	352
2020 Q4	$1.79M	Buy	+5,530	New	+$1.53M	0.03%	362
2020 Q1	–	Sell	-174,818	Closed	-$29.8M	–	540
2019 Q4	$29.8M	Buy	174,818 +31,257	+22%	+$5.79M	0.53%	55
2019 Q3	$25.5M	Buy	143,561 +32,195	+29%	+$6.96M	0.46%	69
2019 Q2	$29M	Buy	111,366 +56,251	+102%	+$14.9M	0.51%	59
2019 Q1	$15.7M	Buy	55,115 +48,185	+695%	+$16M	0.28%	120
2018 Q4	$2.25M	Buy	6,930 +35	+0.5%	+$12.2K	0.05%	301
2018 Q3	$3.1M	Hold	6,895	–	–	0.05%	282
2018 Q2	$2.82M	Buy	+6,895	New	+$2.5M	0.05%	289

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kornitzer Capital Management's ABMD Position: Q4 2022 in Review

Kornitzer Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 6,700 shares — an estimated $1.65M sold.

Kornitzer Capital Management first reported a position in ABMD in Q2 2018 and held it in 15 quarters. The position peaked at $29.8M in Q4 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Kornitzer Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Kornitzer Capital Management sold 6,700 Abiomed Inc shares in Q4 2022, an estimated $1.65M.
Kornitzer Capital Management first reported a position in Abiomed Inc in Q2 2018 and held it in 15 quarters.
Kornitzer Capital Management's Abiomed Inc position peaked at $29.8M in Q4 2019.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Kornitzer Capital Management's 13F filing for Q4 2022, filed 2 Feb 2023.